Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin

Nahathai Dukaew(Chiang Mai University), Ariyaphong Wongnoppavich(Chiang Mai University)
Oncology Reports
July 31, 2020
Cited by 15


Related Papers